ImmunoPrecise Antibodies Ltd. (IPA)

NASDAQ: IPA · Real-Time Price · USD

0.386

-0.022 (-5.42%)

At close: Nov 20, 2024, 4:00 PM

0.396

+0.010 (2.51%)

After-hours: Nov 20, 2024, 6:25 PM EST

ImmunoPrecise Antibodies Market Cap

ImmunoPrecise Antibodies has a market cap or net worth of $11.13 million as of November 21, 2024. Its market cap has decreased by -72.58% in one year.

Market Cap

11.13M

Enterprise Value

19.95M

1-Year Change

-72.58%

Ranking

#5055

Market Cap Chart

Since January 19, 2017, ImmunoPrecise Antibodies's market cap has decreased from $32.77M to $11.13M, a decrease of -66.05%. That is a compound annual growth rate of -12.87%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	11.13M	-75.27%
Dec 29, 2023	45.00M	-65.36%
Dec 30, 2022	129.91M	24.75%
Dec 31, 2021	104.14M	-58.72%
Dec 31, 2020	252.30M	742.75%
Dec 31, 2019	29.94M	-12.68%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Jan 19, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
China Jo-Jo Drugstores	12.54M
Trinity Biotech	12.49M
QT Imaging Holdings	12.11M
Sensei Biotherapeutics	12.07M
Sol-Gel Technologies	12.01M
AIM ImmunoTech	11.59M
Aspira Women's Health	11.44M
Talphera	11.39M

Market Cap Rankings